J Clin Neurol.  2010 Jun;6(2):81-88. 10.3988/jcn.2010.6.2.81.

Predictors of Suicidal Ideation in People with Epilepsy Living in Korea

• Lim HW
• Song HS
• Hwang YH
• Lee HW
• Suh CK
• Park SP
• Kwon SH

• KMID: 2287638
• DOI: http://doi.org/10.3988/jcn.2010.6.2.81

Abstract

BACKGROUND AND PURPOSE
The risk of suicide or suicide attempts is reported higher in people with epilepsy (PWE) than in the general population. Although epileptic, psychiatric, and psychosocial factors are known risk factors for suicide or suicide attempt, no studies have evaluated the predictors of the severity of suicidal ideation-which is a warning sign for suicide attempts-in PWE. Therefore, we measured the severity of suicidal ideation and its risk factors.
METHODS
Consecutive PWE who were medicated with antiepileptic drugs (AEDs) and attended epilepsy clinic were included in the study. The subjects completed self-reported questionnaires, which included the Beck Depression Inventory (BDI), Beck Anxiety Inventory (BAI), Symptom Checklist-90-Revised (SCL-90-R), and Scale for Suicide Ideation-Beck (SSI-Beck). We compared the patients' demographic and clinical variables, and BDI, BAI, and SCL-90-R scores with their SSI-Beck score, and used our findings to determine the predictors for suicidal ideation.
RESULTS
In total, 257 PWE were enrolled in the study. SSI-Beck scores correlated strongly with several seizure-related variables, duration of education, IQ, BDI and BAI scores, and nine domains of the SCL-90-R questionnaire. However, the strongest predictor for suicidal ideation was BDI score (beta=0.41, p<0.001), followed by several SCL-90-R domains, such as obsessive-compulsive (beta=-0.39, p<0.001), depression (beta=0.38, p<0.001), hostility (beta=0.22, p=0.002), paranoid ideation (beta=0.17, p=0.01), and IQ (beta=-0.10, p=0.017). These variables explained 59% of the variance in the SSI-Beck score. The seizure-related variables that influenced the BDI score were seizure frequency, duration of education, MRI abnormality, and number of AEDs. However, these variables explained only 18% of the variance in the BDI score.
CONCLUSIONS
Major risk factors for suicidal ideation in PWE were depressive and psychiatric symptoms rather than seizure-related variables. Therefore, clinicians should focus on screening for depression and other psychiatric problems and treat them appropriately in order to reduce suicidal behavior in PWE. Since seizure-related variables also exhibited a minor role in determining depressive symptoms, stronger seizure-related risk factors for depression should be sought, such as seizure severity or psychosocial factors, to minimize suicidal behavior.

Keyword

epilepsy; suicidal ideation; suicide; depression; psychiatric symptoms; predictors

MeSH Terms

Anticonvulsants
Anxiety
Depression
Epilepsy
Hostility
Korea
Mass Screening
Risk Factors
Seizures
Suicidal Ideation
Suicide
Surveys and Questionnaires
Anticonvulsants

Reference

1. Hendin H, Phillips MR, Vijayuakumar L, Pirkis J, Wang H, Yip P, et al. Epidemiology of suicide in Asia. 2008. Geneva, Switzerland: WHO Document Production Services;7–18.

2. Bark HM. The Trends and Patterns on Suicide in Korea. 2007. Seoul, Korea: Korean Institute of Criminology;93–130.

3. Pompili M, Girardi P, Ruberto A, Tatarelli R. Suicide in the epilepsies: a meta-analytic investigation of 29 cohorts. Epilepsy Behav. 2005. 7:305–310.

4. Christensen J, Vestergaard M, Mortensen PB, Sidenius P, Agerbo E. Epilepsy and risk of suicide: a population-based case-control study. Lancet Neurol. 2007. 6:693–698.

5. Tellez-Zenteno JF, Patten SB, Jetté N, Williams J, Wiebe S. Psychiatric comorbidity in epilepsy: a population-based analysis. Epilepsia. 2007. 48:2336–2344.

6. Jones JE, Hermann BP, Barry JJ, Gilliam FG, Kanner AM, Meador KJ. Rates and risk factors for suicide, suicidal ideation, and suicide attempts in chronic epilepsy. Epilepsy Behav. 2003. 4:Suppl 3. S31–S38.

7. Nilsson L, Ahlbom A, Farahmand BY, Asberg M, Tomson T. Risk factors for suicide in epilepsy: a case control study. Epilepsia. 2002. 43:644–651.

8. Mainio A, Alamäki K, Karvonen K, Hakko H, Särkioja T, Räsänen P. Depression and suicide in epileptic victims: a population-based study of suicide victims during the years 1988-2002 in northern Finland. Epilepsy Behav. 2007. 11:389–393.

9. Kalinin VV, Polyanskiy DA. Gender and suicidality prediction in epilepsy. Epilepsy Behav. 2005. 7:657–663.

10. Ritaccio A, Devinsky O. Ettinger AB, Kanner AM, editors. Personality disorders in epilepsy. Psychiatric issues in epilepsy: a practical guide to diagnose and treatment. 2007. 2nd ed. Philadelphia: Lippincott Williams and Wilkins;147–161.

11. Verrotti A, Cicconetti A, Scorrano B, De Berardis D, Cotellessa C, Chiarelli F, et al. Epilepsy and suicide: pathogenesis, risk factors, and prevention. Neuropsychiatr Dis Treat. 2008. 4:365–370.

12. Brown GK, Beck AT, Steer RA, Grisham JR. Risk factors for suicide in psychiatric outpatients: a 20-year prospective study. J Consult Clin Psychol. 2000. 68:371–377.

13. Mann JJ, Waternaux C, Haas GL, Malone KM. Toward a clinical model of suicidal behavior in psychiatric patients. Am J Psychiatry. 1999. 156:181–189.

14. Jacobs DG, Jamison KR, Baldessarini RJ, Fawcett JA, Hendin H, Gutheil TG. Suicide: clinical/risk management issues for the psychiatrist. CNS Spectrums. 2000. 5:32–54.

15. Jacobs DG, Brewer M, Klein-Benheim M. Jacobs DG, editor. Suicide assessment: an overview and recommended protocol. The Harvard Medical School guide to suicide assessment and intervention. 1999. San Francisco: Jossey-Bass;3–39.

16. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998. 59:Suppl 20. S22–S33.

17. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961. 4:561–571.

18. Beck AT, Kovacs M, Weissman A. Assessment of suicidal intention: the Scale for Suicidal Ideation. J Consult Clin Psychol. 1979. 47:343–352.

19. Kim ZS, Lee YS, Lee MS. Two-and four-subtest short forms of the Korean-Wechsler Adult Intelligence Scale. Seoul J Psychiatry. 1994. 19:121–126.

20. Rhee MK, Lee YH, Jung HY, Choi JH, Kim SH, Kim YK, et al. A standardization study of Beck Depression Inventory II - Korean Version (K-BDI): validity. Korean J Psychopathol. 1995. 4:96–104.

21. Yook SP, Kim ZS. A clinical study on the Korean version of Beck Anxiety Inventory: comparative study of patient and non-patient. Korean J Clin Psychol. 1997. 16:185–197.

22. Kim KI, Kim JH. The standardization study of Symptom Checklist-90-Revision in Korea III. Ment Health Res. 1984. 2:278–311.

23. Shin MS, Park KB, Oh KJ, Kim JS. A study of suicidal ideation among high school students : the structural relation among depression, hopelessness, and suicidal ideation. Korean J Clin Psychol. 1990. 9:1–19.

24. Miller JM, Kustra RP, Vuong A, Hammer AE, Messenheimer JA. Depressive symptoms in epilepsy: prevalence, impact, aetiology, biological correlates and effect of treatment with antiepileptic drugs. Drugs. 2008. 68:1493–1509.

25. Ketter TA, Post RM, Theodore WH. Positive and negative psychiatric effects of antiepileptic drugs in patients with seizure disorders. Neurology. 1999. 53:S53–S67.

26. Blumer D, Montouris G, Davies K, Wyler A, Phillips B, Hermann B. Suicide in epilepsy: psychopathology, pathogenesis, and prevention. Epilepsy Behav. 2002. 3:232–241.

27. Cramer JA, Blum D, Reed M, Fanning K. Epilepsy Impact Project Gruop. The influence of comorbid depression on seizure severity. Epilepsia. 2003. 44:1578–1584.

28. Brent DA, Crumrine PK, Varma RR, Allan M, AlIman C. Phenobarbital treatment and major depressive disorder in children with epilepsy. Pediatrics. 1987. 80:909–917.

29. U.S. Department of Health and Human Services. Food and Drug Administration. Center for Drug Evaluation and Research. Office of Translational Sciences. Office of Biostatistics. Statistical Review and Evaluation: Antiepileptic Drugs and Suicidality. 2008.

30. Hesdorffer DC, Kanner AM. The FDA alert on suicidality and antiepileptic drugs: fire or false alarm? Epilepsia. 2009. 50:978–986.

31. Kanner AM. Psychiatric issues in epilepsy: the complex relation of mood, anxiety disorders, and epilepsy. Epilepsy Behav. 2009. 15:83–87.

32. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983. 67:361–370.

33. Gilliam FG, Barry JJ, Hermann BP, Meador KJ, Vahle V, Kanner AM. Rapid detection of major depression in epilepsy: a multicentre study. Lancet Neurol. 2006. 5:399–405.

34. Harris EC, Barraclough B. Suicide as an outcome for mental disorders. A meta-analysis. Br J Psychiatry. 1997. 170:205–228.

35. Grabowska-Grzyb A, Jedrzejczak J, Nagańska E, Fiszer U. Risk factors for depression in patients with epilepsy. Epilepsy Behav. 2006. 8:411–417.

36. Thompson AW, Miller JW, Katon W, Chaytor N, Ciechanowski P. Sociodemographic and clinical factors associated with depression in epilepsy. Epilepsy Behav. 2009. 14:655–660.